» Authors » E Aingorn

E Aingorn

Explore the profile of E Aingorn including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 109
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Elkin M, Miao H, Nagler A, Aingorn E, Reich R, Hemo I, et al.
FASEB J . 2000 Dec; 14(15):2477-85. PMID: 11099465
We have previously demonstrated that halofuginone, a low molecular weight quinazolinone alkaloid, is a potent inhibitor of collagen alpha1(I) and matrix metalloproteinase 2 (MMP-2) gene expression. Halofuginone also effectively suppresses...
2.
Miao H, Elkin M, Aingorn E, Stein C, Vlodavsky I
Int J Cancer . 1999 Sep; 83(3):424-31. PMID: 10495437
Heparanase activity correlates with the metastatic potential of tumor cells. Moreover, the anti-metastatic effect of non-anti-coagulant species of heparin and certain sulfated polysaccharides was attributed to their heparanase-inhibiting activity. We...
3.
Elkin M, Reich R, Nagler A, Aingorn E, Pines M, de-Groot N, et al.
Clin Cancer Res . 1999 Sep; 5(8):1982-8. PMID: 10473075
Matrix metalloproteinase-2 (MMP-2) plays a critical role in tumor cell invasion and metastasis. Inhibitors of this enzyme effectively suppress tumor metastasis in experimental animals and are currently being tested in...
4.
Miao H, Ornitz D, Aingorn E, Ben-Sasson S, Vlodavsky I
J Clin Invest . 1997 Apr; 99(7):1565-75. PMID: 9120000
Heparan sulfate (HS) proteoglycans play a key role in cell proliferation induced by basic fibroblast growth factor (FGF-2) and other heparin-binding growth factors. To modulate the involvement of HS, we...